{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:14:21Z","timestamp":1791288861205,"version":"4.3.0"},"reference-count":14,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8,1]]},"DOI":"10.1210\/jc.2008-2697","type":"journal-article","created":{"date-parts":[[2009,5,27]],"date-time":"2009-05-27T01:58:53Z","timestamp":1243389533000},"page":"2850-2856","source":"Crossref","is-referenced-by-count":63,"title":["Survival of Patients with Metastatic Malignant Pheochromocytoma and Efficacy of Combined Cyclophosphamide, Vincristine, and Dacarbazine Chemotherapy"],"prefix":"10.1210","volume":"94","author":[{"given":"Kaoru","family":"Nomura","sequence":"first","affiliation":[{"name":"Department of General Medicine (K.N.) Institute of Clinical Endocrinology"},{"name":"Departments of Medicine (K.N., H.Ki., K.T.) Institute of Clinical Endocrinology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironari","family":"Kimura","sequence":"additional","affiliation":[{"name":"Departments of Medicine (K.N., H.Ki., K.T.) Institute of Clinical Endocrinology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Medical Research Institute (S.S.), Tokyo Women\u2019s Medical University, Tokyo 162-8666, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Kodama","sequence":"additional","affiliation":[{"name":"Surgery (H.Ko., T.Ok., T.Ob.), Institute of Clinical Endocrinology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Surgery (H.Ko., T.Ok., T.Ob.), Institute of Clinical Endocrinology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Obara","sequence":"additional","affiliation":[{"name":"Surgery (H.Ko., T.Ok., T.Ob.), Institute of Clinical Endocrinology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazue","family":"Takano","sequence":"additional","affiliation":[{"name":"Departments of Medicine (K.N., H.Ki., K.T.) Institute of Clinical Endocrinology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113563345300_R1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1196\/annals.1353.053","article-title":"Courses of malignant pheochromocytoma. Implication for therapy.","volume":"1073","author":"Sisson","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"key\n\t\t\t\t2019041113563345300_R2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1442-2042.2007.01687.x","article-title":"Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute.","volume":"14","author":"Huang","year":"2007","journal-title":"Int J Urol"},{"key":"key\n\t\t\t\t2019041113563345300_R3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1210\/er.2002-0013","article-title":"Pheochromocytoma: state-of-the-art and future prospects.","volume":"24","author":"Bravo","year":"2003","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041113563345300_R4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1196\/annals.1353.050","article-title":"Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).","volume":"1073","author":"Fitzgerald","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"key\n\t\t\t\t2019041113563345300_R5","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1210\/jc.2006-1544","article-title":"Clinical review: current treatment of malignant pheochromocytoma.","volume":"92","author":"Scholz","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113563345300_R6","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s002689900453","article-title":"Efficacy of single-voided urine metanephrine and normetanephrine assay for diagnosing pheochromocytoma.","volume":"22","author":"Ito","year":"1998","journal-title":"World J Surg"},{"issue":"3 Pt 2","key":"key\n\t\t\t\t2019041113563345300_R7","first-page":"118","article-title":"Treatment of malignant pheochromocytoma with combination chemotherapy","volume":"7","author":"Keiser","year":"1985","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019041113563345300_R8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2169\/internalmedicine1962.29.329","article-title":"A case of malignant pheochromocytoma treated with 131I-metaiodobenzylguanidine and \u03b1-methyl-p-tyrosine.","volume":"29","author":"Nakagami","year":"1990","journal-title":"Jpn J Med"},{"key":"key\n\t\t\t\t2019041113563345300_R9","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/BF03348026","article-title":"The treatment of malignant pheochromocytoma with iodo-131-metabenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients.","volume":"20","author":"Loh","year":"1997","journal-title":"J Endocrinol Invest"},{"key":"key\n\t\t\t\t2019041113563345300_R10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0090-4295(98)00612-8","article-title":"Pheochromocytoma: can malignant potential be predicted?","volume":"53","author":"John","year":"1999","journal-title":"Urology"},{"key":"key\n\t\t\t\t2019041113563345300_R11","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1196\/annals.1353.054","article-title":"Malignant pheochromocytoma in a population-based study. Survival and clinical results.","volume":"1073","author":"Wa\u0308ngberg","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"key\n\t\t\t\t2019041113563345300_R12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1677\/erc.1.00829","article-title":"Malignant pheochromocytoma: current status and initiatives for future progress.","volume":"11","author":"Eisenhofer","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"key\n\t\t\t\t2019041113563345300_R13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1385\/EP:16:1:023","article-title":"Histological grading of adrenal and extra-adrenal pheochromocytoma and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytoma and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors.","volume":"16","author":"Kimura","year":"2005","journal-title":"Endocr Pathol"},{"key":"key\n\t\t\t\t2019041113563345300_R14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/01243894-200606000-00011","article-title":"Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594.","volume":"1","author":"Wakelee","year":"2006","journal-title":"J Thorac Oncol"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/8\/2850\/9065299\/jcem2850.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T10:30:01Z","timestamp":1558348201000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/8\/2850\/2596747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,1]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2008-2697","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,1]]}}}